GoodRx (GDRX) operating income was $87M in FY2025 (+33% YoY). The tables below show the complete quarterly and annual operating income history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Income
Fiscal Year
Operating Income
YoY
2025
$87M
+33%
2024
$66M
+344%
2023
-$27M
-1654%
2022
$2M
-87%
2021
$13M
+105%
2020
-$276M
-297%
2019
$140M
+81%
2018
$77M
Recent Quarterly Operating Income
Quarter
Operating Income
Q2 2026
$24M
Q1 2026
$14M
Q4 2025
$23M
Q3 2025
$15M
Q2 2025
$27M
Q1 2025
$23M
Q4 2024
$18M
Q3 2024
$20M
Q2 2024
$20M
Q1 2024
$7M
Q4 2023
-$18M
Q3 2023
-$38M
Source: GDRX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.